NCT04193748

Brief Summary

This study was conducted to estimate the hypothesis that the Pomegranate Extracts have no role in management of oral lichen planus

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2019

Shorter than P25 for phase_4

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2019

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 10, 2019

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2019

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

3 months

First QC Date

December 8, 2019

Last Update Submit

January 30, 2020

Conditions

Keywords

pomegranate, seeds, peel, topical, Oral lichen planus, pain, OHIP-14.

Outcome Measures

Primary Outcomes (1)

  • visual analog scale (VAS)

    Pain assessment scale

    4 weeks

Secondary Outcomes (2)

  • Sign score

    4 weeks

  • OHIP-14 questionnaire

    4 weeks

Study Arms (3)

Control group

ACTIVE COMPARATOR

Topical triamcinolone acetonide 0.1% available commercially (Kenacort- in orabase) has been used. Topical corticosteroid treatment has be repeated four times per day for four weeks.

Drug: Topical pomegranate seeds and peel extracts

Group S

EXPERIMENTAL

Topical pomegranate seeds extract treatment has been repeated four times per day for four weeks.

Drug: Topical pomegranate seeds and peel extracts

Group P

EXPERIMENTAL

Topical pomegranate peel extract treatment has been repeated four times per day for four weeks.

Drug: Topical pomegranate seeds and peel extracts

Interventions

Topical pomegranate seeds and peel extracts in the form of gel

Control groupGroup PGroup S

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may not qualify if:

  • Patients who excluded from the study were smokers, pregnant, lactating ladies and patients under topical and systemic steroids during the last two months. Uncontrolled diabetic patients or hypertension in addition to hepatic and cardiac patients were not included. In addition, any previous history of allergy to pomegranate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Oral Medicine and Periodontology Department

Cairo, Egypt

Location

Faculty of Dentistry, Cairo University

Giza, Egypt

Location

MeSH Terms

Conditions

Lichen Planus, OralPain

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesLichen PlanusLichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The clinical outcomes were assessed by an investigator masked about the treatment modality that has been used
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Oral Medicine and Periodontology, Cairo University, Egypt

Study Record Dates

First Submitted

December 8, 2019

First Posted

December 10, 2019

Study Start

September 1, 2019

Primary Completion

November 20, 2019

Study Completion

December 13, 2019

Last Updated

February 5, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Because the research not published yet.

Locations